US 9598398
Heterocyclic compound
granted A61PA61P25/00A61P25/08
Quick answer
US patent 9598398 (Heterocyclic compound) held by Takeda Pharmaceutical Company Limited expires Mon Mar 16 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue Mar 21 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 16 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 14
- CPC classes
- A61P, A61P25/00, A61P25/08, A61P25/14, A61P25/16